Publication | Open Access
The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
58
Citations
54
References
2022
Year
AngiogenesisVascular PharmacologyAkt Inhibitor MiransertibVascular MalformationPathologyPi3k‐related Vascular MalformationsVascular BiologyNeovascularizationMedicineCell BiologyCell Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1